Form 8-K - Current report:
SEC Accession No. 0001193125-24-203889
Filing Date
2024-08-21
Accepted
2024-08-20 21:21:59
Documents
15
Period of Report
2024-08-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d859038d8k.htm   iXBRL 8-K 27458
2 EX-99.1 d859038dex991.htm EX-99.1 9118
6 GRAPHIC g859038g0820230258892.jpg GRAPHIC 2200
  Complete submission text file 0001193125-24-203889.txt   167272

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20240816.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20240816_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20240816_pre.xml EX-101.PRE 11255
17 EXTRACTED XBRL INSTANCE DOCUMENT d859038d8k_htm.xml XML 3650
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 241227010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)